Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design
暂无分享,去创建一个
[1] A. Florence,et al. The preparation and properties of niosomes—non‐ionic surfactant vesicles , 1985, The Journal of pharmacy and pharmacology.
[2] D. Rhodes,et al. SEM Imaging Predicts Quality of Niosomes from Maltodextrin-Based Proniosomes , 2001, Pharmaceutical Research.
[3] A. Namdeo,et al. Niosomal delivery of 5-fluorouracil. , 1999, Journal of microencapsulation.
[4] R. New,et al. Liposomes : a practical approach , 1990 .
[5] Y. Chien,et al. Statistical optimization of gastric floating system for oral controlled delivery of calcium , 2001, AAPS PharmSciTech.
[6] M. Khan,et al. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system , 2008, AAPS PharmSciTech.
[7] S. Talegaonkar,et al. Vesicular systems: An overview , 2006 .
[8] D. Rhodes,et al. Proniosomes: a novel drug carrier preparation. , 1999, International journal of pharmaceutics.
[9] D. Rhodes,et al. Maltodextrin-based proniosomes , 2001, AAPS PharmSci.
[10] A. Florence,et al. The effect of non‐ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice , 1985, The Journal of pharmacy and pharmacology.
[11] M. Gohel,et al. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. , 1998, Journal of controlled release : official journal of the Controlled Release Society.